Interventional oncology practices can provide radiology departments with generous revenue despite the costly investment required to provide image-guided therapies.
Interventional oncology practices can provide radiology departments with generous revenue despite the costly investment required to provide image-guided therapies.
Dr. Catherine Tuite and colleagues at the University of Pennsylvania reviewed data from 68 patients who underwent radiofrequency ablation of liver tumors at Penn's outpatient interventional radiology clinic from 1999 to 2003. They recorded all aspects involved with the management of interventional oncology patients, including initial consultation, diagnostic imaging, intervention, and follow-up.
The relative value units drawn against standard payment rates from the Centers for Medicare and Medicaid Services provided the department with total professional revenue of $7000 and $10,000 per each new ablation and chemoembolization patient, respectively. The average revenue to the radiology practice totaled more than $120,000 annually, coauthor Dr. Michael C. Soulen said at the meeting of the Society of Interventional Radiology in April.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.